1. Title of Derivate Security
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date (Month/Day/Year)
|
3A. Deemed Execution Date, if any (Month/Day/Year)
|
4. Transaction Code
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
|
8. Price of Derivative Security
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
|
11. Nature of Indirect Beneficial Ownership
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expriation Date
|
Title
|
Amount or Number of Shares
|
(*)
|
If the form is filed by more than one reporting person, see Instruction 5(b)(v).
|
(**)
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
(1)
|
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2023.
|
(2)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $604.02 to $604.72, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), and (20) to this Form 4.
|
(3)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.12 to $606.07, inclusive.
|
(4)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.17 to $606.61, inclusive.
|
(5)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.29 to $608.20, inclusive.
|
(6)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $608.46 to $609.30, inclusive.
|
(7)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $609.60 to $610.54, inclusive.
|
(8)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $610.61 to $611.40, inclusive.
|
(9)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $611.69 to $612.50, inclusive.
|
(10)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.77 to $613.09, inclusive.
|
(11)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $613.97 to $613.98, inclusive.
|
(12)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $615.00 to $615.01, inclusive.
|
(13)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $603.99 to $604.495, inclusive.
|
(14)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $605.10 to $605.78, inclusive.
|
(15)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $606.56 to $607.54, inclusive.
|
(16)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $607.60 to $608.37, inclusive.
|
(17)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $608.97 to $609.62, inclusive.
|
(18)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $609.99 to $610.70, inclusive.
|
(19)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $611.30 to $612.29, inclusive.
|
(20)
|
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $612.31 to $612.48, inclusive.
|
(21)
|
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
|
(22)
|
The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
|
(23)
|
The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.
|
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
Instruction 6 for procedure.Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.